Rhenman & Partners Asset Management AB - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 176 filers reported holding ALLOGENE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 4.86 and the average weighting 0.1%.

Quarter-by-quarter ownership
Rhenman & Partners Asset Management AB ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$951,000
-36.2%
300,0000.0%0.10%
-34.4%
Q2 2023$1,491,0000.0%300,0000.0%0.16%
-4.3%
Q1 2023$1,491,000
-30.3%
300,000
-11.8%
0.16%
-26.5%
Q4 2022$2,138,600
-38.9%
340,0000.0%0.22%
-39.2%
Q3 2022$3,502,000
-12.2%
340,000
-2.9%
0.37%
-19.0%
Q2 2022$3,990,000350,0000.45%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$16,381,0009.53%
Wildcat Capital Management, LLC 2,128,370$19,389,0004.96%
TPG GP A, LLC 18,716,306$170,506,0002.11%
Pier Capital, LLC 746,669$6,802,0000.87%
Coastal Bridge Advisors, LLC 401,929$3,662,0000.84%
HARBOR CAPITAL ADVISORS, INC. 92,755$845,0000.40%
Lombard Odier Asset Management (Switzerland) SA 501,219$4,566,0000.36%
Navalign, LLC 74,271$623,0000.26%
PDT Partners, LLC 241,592$2,201,0000.19%
GSA CAPITAL PARTNERS LLP 148,804$1,356,0000.18%
View complete list of ALLOGENE THERAPEUTICS INC shareholders